Insulet (NASDAQ:PODD – Get Free Report) and United Health Products (OTCMKTS:UEEC – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability.
Volatility and Risk
Insulet has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Comparatively, United Health Products has a beta of -0.89, indicating that its stock price is 189% less volatile than the S&P 500.
Valuation and Earnings
This table compares Insulet and United Health Products”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Insulet | $2.71 billion | 6.41 | $247.10 million | $3.50 | 70.46 |
| United Health Products | N/A | N/A | -$2.00 million | ($0.02) | -3.42 |
Insulet has higher revenue and earnings than United Health Products. United Health Products is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Insulet and United Health Products’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Insulet | 9.12% | 24.90% | 10.73% |
| United Health Products | N/A | N/A | -2,141.74% |
Institutional & Insider Ownership
0.1% of United Health Products shares are held by institutional investors. 0.4% of Insulet shares are held by company insiders. Comparatively, 1.5% of United Health Products shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current recommendations for Insulet and United Health Products, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Insulet | 1 | 3 | 20 | 0 | 2.79 |
| United Health Products | 0 | 0 | 0 | 0 | 0.00 |
Insulet presently has a consensus price target of $354.57, suggesting a potential upside of 43.78%. Given Insulet’s stronger consensus rating and higher probable upside, analysts plainly believe Insulet is more favorable than United Health Products.
Summary
Insulet beats United Health Products on 11 of the 13 factors compared between the two stocks.
About Insulet
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
About United Health Products
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.
Receive News & Ratings for Insulet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Insulet and related companies with MarketBeat.com's FREE daily email newsletter.
